C9ORF129 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 7.44639999661345E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.75109999999946E-05 |
Normal-vs-Stage2 |
3.423800E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.062000E-02 |
Stage1-vs-Stage2 |
8.347200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.045200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.486000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.25330000000368E-06 |
Normal-vs-AfricanAmerican |
2.974400E-01 |
Normal-vs-Asian |
2.814100E-04 |
Caucasian-vs-AfricanAmerican |
1.999630E-01 |
Caucasian-vs-Asian |
9.110200E-01 |
AfricanAmerican-vs-Asian |
3.669600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.579800E-04 |
Normal-vs-Female |
9.76639999999973E-05 |
Male-vs-Female |
5.347000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.237700E-02 |
Normal-vs-Extreme_Weight |
3.569300E-04 |
Normal-vs-Obese |
4.259900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.494200E-01 |
Normal_Weight-vs-Obese |
6.890000E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.340400E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.04399999651039E-08 |
Normal-vs-Age(41-60Yrs) |
1.364850E-03 |
Normal-vs-Age(61-80Yrs) |
1.815260E-04 |
Normal-vs-Age(81-100Yrs) |
4.301400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.539600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.102700E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.235800E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.516200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.930200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.582600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.255600E-01 |
Normal-vs-Grade 3 |
3.424800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.162400E-01 |
Grade 2-vs-Grade 4 |
7.255600E-01 |
Grade 3-vs-Grade 4 |
3.424800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.87170000000214E-05 |
Normal-vs-N1 |
8.480600E-03 |
N0-vs-N1 |
1.561830E-01 |
|
|